Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803259 | PMC |
http://dx.doi.org/10.1128/JVI.00968-19 | DOI Listing |
Neuromodulation
January 2024
Boomerang Healthcare, Walnut Creek, CA, USA.
Objectives: Recent developments in spinal cord stimulation (SCS) programming have initiated new modalities of imperceptible stimulation. However, the boundaries of sensory perception are not well defined. The BEnchtop NEuromodulation Following endIng of Trial study aimed to create a map of perceptual threshold responses across a broad range of SCS parameters and programming to inform subperception therapy design.
View Article and Find Full Text PDFScapular dyskinesis is an extremely common component of shoulder pathology, especially in the overhead athlete; despite its prevalence, proper diagnosis and management of scapular disorders remains an enigma for many clinicians. An understanding of the contribution of the scapula to pathomechanics and clinical symptoms is necessary to optimize both surgical and nonsurgical treatment of shoulder disorders. Without correction of scapular dysfunction, even effective management of the pathoanatomy is unlikely to produce optimal results.
View Article and Find Full Text PDFArthroscopy
May 2022
The Rothman Institute at Thomas Jefferson University, Philadelphia, Pennsylvania, U.S.A.
The purpose of this paper is to provide updated information for sports healthcare specialists regarding the disabled throwing shoulder (DTS). A panel of experts, recognized for their experience and expertise in this field, was assembled to address and provide updated information on several topics that have been identified as key areas in creating the DTS spectrum. Each panel member submitted a concise presentation on one of the topics within these areas, each of which were then edited and sent back to the group for their comments and consensus agreement in each area.
View Article and Find Full Text PDFSci Rep
December 2019
Sanofi Pasteur, Cambridge, MA, 02139, USA.
Multiple approaches utilizing viral and DNA vectors have shown promise in the development of an effective vaccine against HIV. In this study, an alternative replication-defective flavivirus vector, RepliVax (RV), was evaluated for the delivery of HIV-1 immunogens. Recombinant RV-HIV viruses were engineered to stably express clade C virus Gag and Env (gp120TM) proteins and propagated in Vero helper cells.
View Article and Find Full Text PDFJ Virol
November 2019
Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!